A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT02576938 · COMPLETED
Trial details
- NCT number
- NCT02576938
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-02-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.